University of Chicago: Hypertension trials

The registry lists 16 Hypertension studies with University of Chicago as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 3Phase 3 2Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Intensive Patient Referral and Education Program Prior to Renal Replacement TherapyRecruitingNCT06397456Not applicable
• Mobile Health Management of HypertensionNot yet recruitingNCT05856955Not applicable
• Aspirin and PreeclampsiaRecruitingNCT04479072Phase 4
• Effect of Azilsartan on Aldosterone in Postmenopausal FemalesCompletedNCT01774591Not applicableResults posted
• Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the ArteriesCompletedNCT00829296Phase 2/3Results posted
• Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced HypertensionTerminatedNCT00607477Not applicableResults posted
• Virtual Diabetes Group Visits Across Health SystemsActive, not recruitingNCT06094491Not applicable
• A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African AmericansCompletedNCT06078540Not applicable
• Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American WomenActive, not recruitingNCT05534932Not applicable
• Safety Study of Nebivolol for COPD PatientsWithdrawnNCT01939990Phase 2/3
• A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial HypertensionCompletedNCT01757808Phase 1
• Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise TestingWithdrawnNCT01275703
• Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator TestingWithdrawnNCT01275690
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00452218Phase 1
• Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.TerminatedNCT00409526Phase 4
• Sildenafil and Pulmonary Artery PressureTerminatedNCT00145938Phase 2